{
    "organizations": [],
    "uuid": "e658965f44b2d3b9645e733f587ba37037566d53",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-atyr-pharma-inc-posts-qtrly-loss-o/brief-atyr-pharma-inc-posts-qtrly-loss-of-0-36-per-share-idUSASC0A1VQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Atyr Pharma Inc Posts Qtrly Loss Of $0.36 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - aTyr Pharma Inc:\n* ATYR PHARMA ANNOUNCES FIRST QUARTER 2018 OPERATING RESULTS, PROGRAM PRIORITIZATION AND CORPORATE RESTRUCTURING\n* CORPORATE RESTRUCTURING INCLUDES AN IMMEDIATE WORKFORCE REDUCTION OF APPROXIMATELY 30% AS WELL AS ADDITIONAL COST SAVING MEASURES\n* RESTRUCTURING PLAN TO STREAMLINE ITS OPERATIONS AS IT FOCUSES ITS DEVELOPMENT EFFORTS ON FURTHER CLINICAL ADVANCEMENT OF ATYR1923\n* ATYR PHARMA - NOT TO PROCEED WITH IND-ENABLING ACTIVITIES, INCLUDING GMP MANUFACTURING, FOR PANEL OF ANTIBODIES IDENTIFIED IN ORCA PROGRAM\n* QTRLY LOSS PER SHARE $0.36 * Q1 EARNINGS PER SHARE VIEW $-0.36 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\n© 2018 Reuters. All Rights Reserved.",
    "published": "2018-05-14T18:57:00.000+03:00",
    "crawled": "2018-05-15T14:15:37.038+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "atyr",
        "pharma",
        "inc",
        "atyr",
        "pharma",
        "announces",
        "first",
        "quarter",
        "operating",
        "result",
        "program",
        "prioritization",
        "corporate",
        "restructuring",
        "corporate",
        "restructuring",
        "includes",
        "immediate",
        "workforce",
        "reduction",
        "approximately",
        "well",
        "additional",
        "cost",
        "saving",
        "measure",
        "restructuring",
        "plan",
        "streamline",
        "operation",
        "focus",
        "development",
        "effort",
        "clinical",
        "advancement",
        "atyr1923",
        "atyr",
        "pharma",
        "proceed",
        "activity",
        "including",
        "gmp",
        "manufacturing",
        "panel",
        "antibody",
        "identified",
        "orca",
        "program",
        "qtrly",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle",
        "apps",
        "newsletter",
        "reuters",
        "plus",
        "advertising",
        "guideline",
        "cooky",
        "term",
        "use",
        "privacy",
        "quote",
        "delayed",
        "minimum",
        "minute",
        "see",
        "complete",
        "list",
        "exchange",
        "delay",
        "reuters",
        "right",
        "reserved"
    ]
}